Ironically I think the shorts and paid-per-post FUDsters already know they lost. The clinical trial was a landmark success, marketing application submitted, and a DCVax-L approval is only a question of when, not if. Plus NWBO retail investors are due diligence hardened and will not sell for anything less than a sufficient premium over the intrinsic value, if at all. Ideally NWBO remains transitions into a big pharma and becomes a high growth company for multiple decades.
But today... the shorts continue to hit the stock price daily, hoping. The FUDsters continue to post, wrapping their package of facts, lies, misdirection, and misery with a bowtie and delivering it as a trojan horse gift to retail investors, daily, hoping.
"Victorious warriors win first and then go to war, while defeated warriors go to war first and then seek to win.” - Sun Tzu
Bullish
Market Data 
Markets 
AI
